Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~43 mi. (Berlin, Germany, +94 more cities)

Charité Universitätsmedizin Campus Charité Mitte

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

~43 mi. (Berlin, Germany, +120 more cities)

Charité - Universitatsmedizin Berlin

FGFR3 A391E, +9 more biomarkers

Urothelial Carcinoma

infigratinib

targeted therapy

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~49 mi. (Dessau, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

~49 mi. (Dessau, Germany, +37 more cities)

Stadtisches Klinikum Dessau

ER Negative, +2 more biomarkers

Breast Carcinoma

ladiratuzumab vedotin, +1 more drug

chemotherapy, +2 more types

Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma

~69 mi. (Bad Saarow, Germany, +27 more cities)

Helios Hospital Bad Saarow, Clinic for Hematology, Oncology and Palliative Medicine

Dedifferentiated Liposarcoma

milademetan

targeted therapy

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

~70 mi. (Magdeburg, Germany, +159 more cities)

Universitaetsklinikum Magdeburg A.o.R. ( Site 0516)

Superficial Bladder Urothelial Carcinoma

cisplatin, +2 more drugs

chemotherapy, +1 more type

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

~70 mi. (Magdeburg, Germany, +163 more cities)

Universitaetsklinikum Magdeburg A.o.R. ( Site 0535)

Bladder Urothelial Carcinoma

cystectomy, +2 more drugs

chemotherapy, +3 more types

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~76 mi. (Niemberg, Germany, +93 more cities)

Klinikum Nuernberg Nord ( Site 1300)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~84 mi. (Halle (Saale), Germany, +140 more cities)

Universitaetsklinikum Halle ( Site 0213)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~84 mi. (Halle (Saale), Germany, +142 more cities)

Universitaetsklinik und Polikl

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~84 mi. (Halle (Saale), Germany, +228 more cities)

Krankenhaus Martha-Maria Halle-Doelau /ID# 205442

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

~84 mi. (Halle (Saale), Germany, +16 more cities)

Site DE49001

FLT3 ITD

Acute Myeloid Leukemia

cytarabine, +3 more drugs

chemotherapy, +2 more types